1. Home
  2. RGEN vs NICE Comparison

RGEN vs NICE Comparison

Compare RGEN & NICE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Repligen Corporation

RGEN

Repligen Corporation

N/A

Current Price

$181.13

Market Cap

6.6B

Sector

Health Care

ML Signal

N/A

Logo NICE Ltd

NICE

NICE Ltd

N/A

Current Price

$100.24

Market Cap

5.6B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
RGEN
NICE
Founded
1981
1986
Country
United States
Israel
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.6B
5.6B
IPO Year
1995
1999

Fundamental Metrics

Financial Performance
Metric
RGEN
NICE
Price
$181.13
$100.24
Analyst Decision
Buy
Buy
Analyst Count
12
13
Target Price
$167.67
$153.46
AVG Volume (30 Days)
1.2M
602.3K
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
286.96
N/A
EPS
0.24
N/A
Revenue
$141,236,000.00
N/A
Revenue This Year
$14.30
$10.14
Revenue Next Year
$14.52
$9.62
P/E Ratio
$751.21
$11.21
Revenue Growth
35.10
N/A
52 Week Low
$100.99
$83.10
52 Week High
$188.73
$153.62

Technical Indicators

Market Signals
Indicator
RGEN
NICE
Relative Strength Index (RSI) 76.48 51.06
Support Level $156.65 $95.88
Resistance Level N/A $104.84
Average True Range (ATR) 6.79 3.86
MACD 1.81 -0.29
Stochastic Oscillator 84.69 48.34

Price Performance

Historical Comparison
RGEN
NICE

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

About NICE NICE Ltd

Nice is an enterprise software company that serves the customer engagement and financial crime and compliance markets. Software is deployed primarily on the cloud, but also on premises. Within customer engagement, Nice's CXone is the leading CCaaS platform providing solutions such as call routing, interactive voice response, digital self-service, and workforce engagement management. Within financial crime and compliance, Nice offers risk and investigation management, fraud prevention, anti-money-laundering, and compliance solutions.

Share on Social Networks: